Dr. MiltieAtlas by Dr. Miltie™Nationwide Grant Intelligence

Atlas Grant Intelligence Center

International Myeloma Society / Paula and Rodger Riney Foundation

Verified healthcare funding opportunities organized by funding organization: International Myeloma Society / Paula and Rodger Riney Foundation. Review the public Atlas Opportunity Score, then request an organization-specific analysis when an opportunity looks promising.

Atlas IndexFunding Organization Intelligence
Latest verification: 2026-11-06
Verified records2
Active opportunities2
Top opportunity scoreUnder review
States represented1

GeographyInternational

← All Healthcare Grants Funding Organization
OPEN: 2027 IMS Translational Research Award. Full applications due January 29, 2027 at 11:59 p.m. EST.
Verified 2026-11-06

International Myeloma Society / Paula and Rodger Riney Foundation

International — IMS / Riney Foundation 2027 Translational Research Grants ($175,000–$250,000; January 29 EST)

2027 IMS Translational Research Award. $175,000–$250,000 USD for an individual investigator's initial research project award, including institutional overhead up to 8%. Second-year support may be considered separately following research progress and available funding; no unconditional two-year ceiling is established. Due January 29, 2027 at 11:59 p.m. EST; specific investigator qualifications and award restrictions apply.

Funding$175,000–$250,000 USD for an individual investigator's initial research project award, including institutional overhead up to 8%. Second-year support may be considered separately following research progress and available funding; no unconditional two-year ceiling is established.
DeadlineOPEN. Full application due January 29, 2027 at 11:59 p.m. Eastern Standard Time. The current controlling program documentation and IMS announcement agree on this deadline.
Required next actionCheck eligibility (Established faculty member or other scientist with M.D. and/or Ph.D. conducting translational research relevant to multiple myeloma or other plasma cell dyscrasias. Researchers entering myeloma from other fields may qualify. A Principal Investigator or co-investigator must be an IMS member; previously funded investigators cannot apply with an unrelated new proposal.) and controlling instructions https://www.myelomasociety.org/grants/international-myeloma-society-ims-and-paula-and-rodger-riney-foundation-translational-research-grant/; register/login to https://myelomasociety.flexigrant.com/; prepare Institution-approved application, five-page research plan (specific aims, significance, innovation, preliminary data, methods), references (up to 25), investigator CV/biosketch, eligibility and translational endpoint statement, itemized budget and justification. Submit complete application by January 29, 2027 at 11:59 p.m. Eastern Standard Time.
OPEN: 2027 IMS Career Development Award. Full applications due January 29, 2027 at 11:59 p.m. EST.
Verified 2026-11-06

International Myeloma Society / Paula and Rodger Riney Foundation

International — IMS 2027 Career Development Research Grants (Up to $75,000; January 29 EST)

2027 IMS Career Development Award. Up to $75,000 USD for an individual one-year career development award, inclusive of permitted institutional overhead up to 8%. Approximately $3 million is the combined 2027 IMS research program pool, not an applicant award ceiling. Due January 29, 2027 at 11:59 p.m. EST; specific investigator qualifications and award restrictions apply.

FundingUp to $75,000 USD for an individual one-year career development award, inclusive of permitted institutional overhead up to 8%. Approximately $3 million is the combined 2027 IMS research program pool, not an applicant award ceiling.
DeadlineOPEN. Full application due January 29, 2027 at 11:59 p.m. Eastern Standard Time. The current controlling program documentation and IMS announcement agree on this deadline.
Required next actionCheck eligibility (Emerging scientist with M.D. or Ph.D., or currently completing a Ph.D. in plasma cell dyscrasia research, who is not yet an independent investigator, has not received NIH independent research funding or an international equivalent, and plans a research career in plasma cell disorders. Applicant must arrange a distinct host laboratory outside their home institution and local metropolitan area; existing employment agreement with the host laboratory is disqualifying. Home- or host-institution PI must be an IMS member. Host labs may submit one application per cycle.) and controlling instructions https://www.myelomasociety.org/grants/ims-career-development-award/; register/login to https://myelomasociety.flexigrant.com/; prepare Home-institution-approved research application, up to five-page proposal including one-page specific aims, up to 25 references, career development statement, applicant CV, home/host PI biosketches, signed letters from home institution and separate host mentor, itemized budget and justification. Submit complete application by January 29, 2027 at 11:59 p.m. Eastern Standard Time.